Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial
pharma_trial_failureGlobalWSJ7 Sept, 08:14 UTC
Context
Novartis Shares Fall After Heart Drug Misses Target in Late-Stage Trial wsj.com Pharma major Novartis plummets 10%, heading for worst day on record after three drug trial setbacks CNBC Another Heart Drug Fails, Shocking Cardiologists nytimes.com Novartis shares sink on second pipeline setback this week Reuters Novartis’s Latest Trial Setback Sinks Stock wsj.com
What it means
Causal chain
No clear market signal
How to read a signal
- Severity
- the event's market impact, 1–5
- Direction
- ↑ / ↓ likely price move for the asset
- Exp. move
- the size of the abnormal move we'd expect if the call plays out — not a claim a move will happen:Most flagged events don't move beyond noise; those count against us (see the track record).Ssmall<1%Mmoderate1–5%Llarge>5%
- Timeframe
- the window we measure over:1dshort5dmedium21dlong
- Conviction
- how well-established the directional call is (textbook → speculative) — not a guaranteed outcome:lowaveragestrong
Get the next signal the moment it breaks.
The full live feed, asset filters, and alerts — free.
Sign up free →Not investment advice · for informational purposes only. Generated 8 Sept, 09:48 UTC